Exhibit 5.1
| | |
| | 787 Seventh Avenue New York, NY 10019-6099 Tel: 212 728 8000 Fax: 212 728 8111 |
March 2, 2021
Fidelity National Information Services, Inc.
601 Riverside Avenue
Jacksonville, Florida 32204
| Re: | Fidelity National Information Services, Inc. |
0.375% Senior Notes due 2023, 0.600% Senior Notes due 2024, 1.150% Senior Notes due 2026, 1.650% Senior Notes due 2028, 2.250% Senior Notes due 2031 and 3.100% Senior Notes due 2041
Ladies and Gentlemen:
We have acted as special counsel for Fidelity National Information Services, Inc., a Georgia corporation (the “Company”), in connection with the issuance and sale of $750,000,000 aggregate principal amount of 0.375% Senior Notes due 2023, $750,000,000 aggregate principal amount of 0.600% Senior Notes due 2024, $1,250,000,000 aggregate principal amount of 1.150% Senior Notes due 2026, $750,000,000 aggregate principal amount of 1.650% Senior Notes due 2028, $1,250,000,000 aggregate principal amount of 2.250% Senior Notes due 2031 and $750,000,000 aggregate principal amount of 3.100% Senior Notes due 2041 (collectively, the “Securities”), pursuant to the Underwriting Agreement, dated February 23, 2021 (the “Underwriting Agreement”), among the Company and the underwriters listed on Schedule 1 thereto (the “Underwriters”). The Securities will be issued pursuant to an Indenture, dated as of April 15, 2013 (the “Base Indenture”), among the Company, certain other parties thereto and The Bank of New York Mellon Trust Company, N.A., as trustee (the “Trustee”), as amended by a Thirtieth Supplemental Indenture, to be dated as of March 2, 2021 (the “Thirtieth Supplemental Indenture”), a Thirty-First Supplemental Indenture, to be dated as of March 2, 2021 (the “Thirty-First Supplemental Indenture”), a Thirty-Second Supplemental Indenture, to be dated as of March 2, 2021 (the “Thirty-Second Supplemental Indenture”), a Thirty-Third Supplemental Indenture, to be dated as of March 2, 2021 (the “Thirty-Third Supplemental Indenture”), a Thirty-Fourth Supplemental Indenture, to be dated as of March 2, 2021 (the “Thirty-Fourth Supplemental Indenture”) and a Thirty-Fifth Supplemental Indenture, to be dated as of March 2, 2021 (the “Thirty-Fifth Supplemental Indenture” and, together with the Thirtieth Supplemental Indenture, the Thirty-First Supplemental Indenture, the Thirty-Second Supplemental Indenture, the Thirty-Third Supplemental Indenture and the Thirty-Fourth Supplemental Indenture, the “Supplemental Indentures” and, collectively with the Base Indenture, the “Indenture”).
The offer and sale of the Securities is being made pursuant to the Registration Statement (the “Registration Statement”) on Form S-3 (Registration No. 333-232920), relating to the Securities and other securities, filed by the Company with the Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended (the “Securities Act”), including the prospectus supplement, dated February 23, 2021 (the “Prospectus Supplement”), filed by the Company with the Commission on February 23, 2021. This opinion is being furnished in connection with the requirements of Item 601(b)(5) of Regulation S-K under the Securities Act.
NEW YORK WASHINGTON HOUSTON PALO ALTO SAN FRANCISCO CHICAGO
PARIS LONDON FRANKFURT BRUSSELS MILAN ROME